{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:53:13Z","timestamp":1786719193444,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Thorac Med"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/atm.atm_147_20","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T05:00:56Z","timestamp":1592456456000},"page":"118","source":"Crossref","is-referenced-by-count":28,"title":["Amphotericin B as antiviral drug: Possible efficacy against COVID-19"],"prefix":"10.4103","volume":"15","author":[{"given":"FalahHasan Obayes","family":"AL-Khikani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1817-1737.287135-1","first-page":"187","volume-title":"Topical Amphotericin B formulas: Promising new application","author":"AL-Khikani","year":"2019","journal-title":"International Journal of Medical Science and Current Research"},{"key":"key-10.4103\/1817-1737.287135-2","first-page":"71","volume-title":"Liposomal amphotericin B: What is its role in 2008.?","author":"Lanternier","year":"2008","journal-title":"Clinical Microbiology and Infection"},{"key":"key-10.4103\/1817-1737.287135-3","first-page":"71\u201374","volume-title":"Host-directed therapies for improving poor treatment outcomes associated with the Middle East respiratory syndrome coronavirus infections","author":"Zumla","year":"2015","journal-title":"Int J Infect Dis"},{"key":"key-10.4103\/1817-1737.287135-4","first-page":"26971","volume-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019nCoV) in vitro","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"key-10.4103\/1817-1737.287135-5","first-page":"457","volume-title":"Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst","author":"Sangalli-Leite","year":"2011","journal-title":"Microbes and Infection"},{"key":"key-10.4103\/1817-1737.287135-6","first-page":"1","volume-title":"It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug","author":"Mesa-Arango","year":"2012","journal-title":"Frontiers in Microbiology"},{"key":"key-10.4103\/1817-1737.287135-7","first-page":"37561","volume-title":"The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor-and CD14-dependent mechanism.Journal of Biological Chemistry","author":"Sau","year":"2003","journal-title":""},{"key":"key-10.4103\/1817-1737.287135-8","doi-asserted-by":"crossref","unstructured":"Arning M, Kliche KO, Heer-Sonderhoff AH, Wehmeier A. Mycoses 1995;38:459-65.","DOI":"10.1111\/j.1439-0507.1995.tb00020.x"},{"key":"key-10.4103\/1817-1737.287135-9","first-page":"197","volume-title":"Anti-HIV activity of amphotericin B-cholesteryl sulfate colloidal dispersion in vitro","author":"Konopka","year":"1999","journal-title":"Antiviral Res"},{"key":"key-10.4103\/1817-1737.287135-10","first-page":"121","volume-title":"Antiviral effect of amphotericin B on Japanese encephalitis virus replication","author":"Kim","year":"2004","journal-title":"Journal of microbiology and biotechnology"},{"key":"key-10.4103\/1817-1737.287135-11","doi-asserted-by":"crossref","unstructured":"Shiota H, Jones BR, Schaffner CP. Anti-Herpes Simplex Virus (HSV) Effect of Amphotericin B Methyl Ester in Vivo. In Parasites, Fungi, and Viruses; Springer, Boston, MA: 1976. p. 339-46.","DOI":"10.1007\/978-1-4684-3129-2_49"},{"key":"key-10.4103\/1817-1737.287135-12","first-page":"919","volume-title":"Amphotericin B formulations: A comparative review of efficacy and toxicity","author":"Hamill","year":"2013","journal-title":"Drugs"},{"key":"key-10.4103\/1817-1737.287135-13","first-page":"2405","volume-title":"Amphotericin B formulations and drug targeting","author":"Torrado","year":"2008","journal-title":"Journal of pharmaceutical sciences"},{"key":"key-10.4103\/1817-1737.287135-14","doi-asserted-by":"crossref","unstructured":"ALKhikani FH. Pulmonary mycoses treated by topical amphotericin B. Biomed Biotechnol Res J 2020. DOI: 10.4103\/bbrj.bbrj_12_20.","DOI":"10.4103\/bbrj.bbrj_12_20"},{"key":"key-10.4103\/1817-1737.287135-15","first-page":"1329","volume-title":"Synthesis and biological evaluation of amphotericin B derivatives","author":"Volmer","year":"2010","journal-title":"Natural Product Reports"},{"key":"key-10.4103\/1817-1737.287135-16","first-page":"146","volume-title":"Efficacy and safety of amphotericin B lipid-based formulations\u2014A systematic review and meta-analysis","author":"Steimbach","year":"2017","journal-title":"Mycoses"},{"key":"key-10.4103\/1817-1737.287135-17","first-page":"485","volume-title":"Liposomal amphotericin B (AmBisome\u00ae): A review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"key-10.4103\/1817-1737.287135-18","first-page":"2234","volume-title":"Amphotericin primarily kills yeast by simply binding ergosterol","author":"Gray","year":"2012","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"key-10.4103\/1817-1737.287135-19","first-page":"377","volume-title":"How does amphotericin B work.: Studies on model membrane systems?","author":"Hartsel","year":"1993","journal-title":"Journal of Liposome Research"},{"key":"key-10.4103\/1817-1737.287135-20","first-page":"208","volume-title":"Temperature-dependent transfer of amphotericin B from liposomal membrane of AmBisome to fungal cell membrane","author":"Shimizu","year":"2010","journal-title":"Journal of Controlled Release"},{"key":"key-10.4103\/1817-1737.287135-21","doi-asserted-by":"crossref","unstructured":"Fehr AR, Perlman S. Coronaviruses: An overview of their replication and pathogenesis. InCoronaviruses. Humana Press, New York, NY. 2015. p. 1-23.","DOI":"10.1007\/978-1-4939-2438-7_1"},{"key":"key-10.4103\/1817-1737.287135-22","doi-asserted-by":"crossref","unstructured":"Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. \u201cThe proximal origin of SARS-CoV-2.\u201d Nature Medicine 2020. p. 1-3.","DOI":"10.1038\/s41591-020-0820-9"},{"key":"key-10.4103\/1817-1737.287135-23","first-page":"81","volume-title":"Surveillance 2019 novel coronavirus (COVID-19) spreading: Is a terrifying pandemic outbreak is soon.??","author":"AL-Khikani","year":"2020","journal-title":"Biomed Biotechnol Res J","ISSN":"https:\/\/id.crossref.org\/issn\/2588-9834","issn-type":"print"},{"key":"key-10.4103\/1817-1737.287135-24","unstructured":"AL-Khikani FH. The role of blood group in COVID-19 infection: More information is needed. J Nat Sci Med 2020."},{"key":"key-10.4103\/1817-1737.287135-25","unstructured":"National Health Commission of the People's Republic of China. Notice on printing and distributing the diagnosis and treatment plan of pneumonia with new coronavirus infection (trial version 3). http:\/\/www.nhc.gov.cn\/yzygj\/ s7653p\/202001\/f492c9153ea9437bb587ce2ffcbee1fa. shtml. [Last accessed on 2020 Jan 23]."},{"key":"key-10.4103\/1817-1737.287135-26","first-page":"105923","volume-title":"Chloroquine for the 2019 novel coronavirus SARSCoV2","author":"Colson","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/1817-1737.287135-27","first-page":"405","volume-title":"Effects of MS-8209, an amphotericin B derivative, on tumor necrosis factor alpha synthesis and human immunodeficiency virus replication in macrophages","author":"Clayette","year":"2000","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"key-10.4103\/1817-1737.287135-28","first-page":"2","volume-title":"Identification of adjuvantic activity of amphotericin B in a novel, multiplexed, poly-TLR\/NLR high-throughput screen.PLoS One","author":"Salyer","year":"2016","journal-title":""},{"key":"key-10.4103\/1817-1737.287135-29","unstructured":"Rice CM. Flaviviridae: the viruses and their replication, In Fields BN, Knipe DM, Howley PM, (eds.), Fields Virology, 3rd ed. LippincottRaven Publishers, Philadelphia, PA. U.S.A. 1996. p. 931-59."},{"key":"key-10.4103\/1817-1737.287135-30","first-page":"570","volume-title":"Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion","author":"Pleskoff","year":"1995","journal-title":"Journal of virology"},{"key":"key-10.4103\/1817-1737.287135-31","first-page":"86","volume-title":"Modulation of the severe CD4() T-cell loss caused by a pathogenic simian-human immunodeficiency virus by replacement of the subtype B vpu with the vpu from a subtype C HIV-1 clinical isolate","author":"Hill","year":"2008","journal-title":"Virology"},{"key":"key-10.4103\/1817-1737.287135-32","first-page":"119","volume-title":"Inhibition of HIV replication by liposomal encapsulated amphotericin B","author":"Pontani","year":"1989","journal-title":"Antiviral research"},{"key":"key-10.4103\/1817-1737.287135-33","first-page":"1369","volume-title":"Inhibition of rubella virus growth by Fungizone.Vaccine","author":"Umino","year":"2001","journal-title":""},{"key":"key-10.4103\/1817-1737.287135-34","first-page":"826","volume-title":"Effects of amphotericin B on hepatitis B virus","author":"Kessler","year":"1981","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"key-10.4103\/1817-1737.287135-35","first-page":"119","volume-title":"Combined effect of acyclovir and amphotericin B on the replication of pseudorabies virus in BHK-21 cells.Antimicrobial agents and chemotherapy","author":"Malewicz","year":"1983","journal-title":""},{"key":"key-10.4103\/1817-1737.287135-36","first-page":"340","volume-title":"Effect of amphotericin B methyl ester on vesicular stomatitis virus morphology","author":"Jordan","year":"1978","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"key-10.4103\/1817-1737.287135-37","first-page":"33150","volume-title":"Amphotericin B inhibits enterovirus 71 replication by impeding viral entry.Scientific reports","author":"Xu","year":"2016","journal-title":""}],"container-title":["Annals of Thoracic Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:45:11Z","timestamp":1786715111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/atm.ATM_147_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"alternative-id":["287135"],"URL":"https:\/\/doi.org\/10.4103\/atm.atm_147_20","relation":{},"ISSN":["1817-1737"],"issn-type":[{"value":"1817-1737","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}